{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:15:39Z","timestamp":1794255339930,"version":"4.9.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009634","name":"Susan G. Komen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1R01CA227156-01"],"award-info":[{"award-number":["1R01CA227156-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TESARO, Inc."}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ygyno.2019.03.004","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T18:57:31Z","timestamp":1552417051000},"page":"568-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Increased risk of brain metastases in ovarian cancer patients with BRCA mutations"],"prefix":"10.1016","volume":"153","author":[{"given":"Elena","family":"Ratner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Bala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Louie-Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Hazard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2019.03.004_bb0005","series-title":"Cancer Stat Facts: Ovarian Cancer","author":"National Cancer Institute","year":"2018"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0010","doi-asserted-by":"crossref","unstructured":"K.B. Kuchenbaecker, J.L. Hopper, D.R. Barnes, K.A. Phillips, T.M. Mooij, M.J. Roos-Blom, et al, Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers, JAMA. 317 (2017) 2402\u20132416.","DOI":"10.1001\/jama.2017.7112"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0015","first-page":"1","article-title":"Genetic cancer ovary","volume":"7","author":"Osman","year":"2014","journal-title":"Clin. Ovarian Other Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0020","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1056\/NEJMra012284","article-title":"Breast and ovarian cancer","volume":"348","author":"Wooster","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0025","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/sj.onc.1209874","article-title":"The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability","volume":"25","author":"Gudmundsdottir","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0030","doi-asserted-by":"crossref","unstructured":"J.M. Cunningham, M.S. Cicek, N.B. Larson, J. Davila, C. Wang, M.C. Larson, et al, Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status, Sci. Rep. 4 (2014) 4026.","DOI":"10.1038\/srep04026"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-014-1447-9","article-title":"Brain metastasis from ovarian cancer: a systematic review","volume":"119","author":"Pakneshan","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0040","first-page":"2793","article-title":"Brain metastases from epithelial ovarian cancer: overview and optimal management","volume":"29","author":"Pietzner","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1634\/theoncologist.11-3-252","article-title":"Brain metastases from epithelial ovarian cancer: a review of the literature","volume":"11","author":"Pectasides","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0050","article-title":"Brain metastases from ovarian carcinoma","volume":"2011","author":"Piura","year":"2011","journal-title":"ISRN Oncol."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0055","doi-asserted-by":"crossref","unstructured":"D.F. Kolomainen, J.M. Larkin, M. Badran, R.P. A'Hern, D.M. King, C. Fisher C, et al, Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence, J. Clin. Oncol. 20 (2002) 982\u2013986.","DOI":"10.1200\/JCO.2002.20.4.982"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0060","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1447-0756.2012.01961.x","article-title":"Increased incidence of brain metastases in BRCA1-related ovarian cancers","volume":"39","author":"Sekine","year":"2013","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0065","doi-asserted-by":"crossref","unstructured":"S. Balendran, S. Liebmann-Reindl, A.S. Berghoff, T. Reischer, N. Popitsch, C.B. Geier, et al, Next-generation sequencing-based genomic profiling of brain metastases of primary ovarian cancer identifies high number of BRCA-mutations, J. Neuro-Oncol. 133 (2017) 469\u2013476.","DOI":"10.1007\/s11060-017-2459-z"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0070","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1200\/JCO.2011.41.5919","article-title":"Solitary brain metastasis in a patient with ovarian cancer with BRCA2 mutation","volume":"30","author":"Root","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2017.00230","article-title":"Genetic characterization of brain metastases in the era of targeted therapy","volume":"7","author":"Han","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0080","series-title":"Breast Cancer Treatment (PDQ\u00ae)\u2013Health Professional Version","author":"National Cancer Institute","year":"2018"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0085","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/COC.0000000000000466","article-title":"BRCA1 mutations associated with increased risk of brain metastases in breast cancer: a 1: 2 matched-pair analysis","volume":"41","author":"Zavitsanos","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0090","doi-asserted-by":"crossref","unstructured":"L. J. Lee, B. Alexander, S.J. Schnitt, A. Comander, B. Gallagher, J.E. Garber, et al, Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers, Cancer. 117 (2011) 3093\u20133100.","DOI":"10.1002\/cncr.25911"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0095","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/annonc\/mdi351","article-title":"Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases","volume":"16","author":"Albiges","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0100","first-page":"e315","article-title":"Brain metastases in pancreatic ductal adenocarcinoma: assessment of molecular genotype-phenotype features-an entity with an increasing incidence?","volume":"17","author":"Jordan","year":"2018","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.ygyno.2019.03.004_bb0105","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.ijrobp.2017.06.495","article-title":"Targeted DNA sequencing of nonsmall cell lung cancer identifies mutations associated with brain metastases","volume":"99","author":"Hauck","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2019.03.004_bb0110","doi-asserted-by":"crossref","unstructured":"A. Antoniou, P.D.P. Pharoah, S. Narod, H.A. Risch, J.E. Eyfjord, J.L. Hopper, et al, Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies, Am. J. Hum. Genet. 72 (2003) 1117\u20131130.","DOI":"10.1086\/375033"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819301520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819301520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:47:18Z","timestamp":1758772038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819301520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0090825819301520"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased risk of brain metastases in ovarian cancer patients with BRCA mutations","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}